Zepzelca (lurbinectedin) for the Treatment of Small Cell Lung Cancer

Zepzelca (lurbinectedin) was approved by the FDA in June 2020. Credit: Shutterstock



  • Zepzelca (lurbinectedin)
  • Zepzelca (lurbinectedin)
  • Zepzelca (lurbinectedin)